Similar articles for PMID: 27146612

Year	Number of Results
2007	2
2008	4
2009	5
2010	4
2011	10
2012	17
2013	8
2014	17
2015	19
2016	13
2017	20
2018	8
2019	9
2020	17
2021	21
2022	6

1

Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study.

Alnegheimish NA, Alshatwi RA, Alhefdhi RM, Arafah MM, AlRikabi AC, Husain S. Alnegheimish NA, et al. Saudi Med J. 2016 May;37(5):506-12. doi: 10.15537/smj.2016.5.15000. Saudi Med J. 2016. PMID: 27146612 Free PMC article.

2

Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.

Cherbal F, Gaceb H, Mehemmai C, Saiah I, Bakour R, Rouis AO, Boualga K, Benbrahim W, Mahfouf H. Cherbal F, et al. Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398. Breast Dis. 2015. PMID: 25736840

3

Molecular classification of breast cancer: A retrospective cohort study.

Al-Thoubaity FK. Al-Thoubaity FK. Ann Med Surg (Lond). 2019 Dec 6;49:44-48. doi: 10.1016/j.amsu.2019.11.021. eCollection 2020 Jan. Ann Med Surg (Lond). 2019. PMID: 31890196 Free PMC article.

4

Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.

Elkablawy MA, Albasri AM, Mohammed RA, Hussainy AS, Nouh MM, Alhujaily AS. Elkablawy MA, et al. Saudi Med J. 2016 Feb;37(2):137-41. doi: 10.15537/smj.2016.2.12285. Saudi Med J. 2016. PMID: 26837394 Free PMC article.

5

Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.

Park C, Park K, Kim J, Sin Y, Park I, Cho H, Yang K, Bae BN, Kim KW, Ahn S, Gwak G. Park C, et al. World J Surg Oncol. 2016 Sep 13;14(1):244. doi: 10.1186/s12957-016-0999-x. World J Surg Oncol. 2016. PMID: 27619909 Free PMC article.

6

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A. Basu S, et al. Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226. Cancer. 2008. PMID: 18098228 Free article. Clinical Trial.

7

Can breast cancer molecular subtype help to select patients for preoperative MR imaging?

Grimm LJ, Johnson KS, Marcom PK, Baker JA, Soo MS. Grimm LJ, et al. Radiology. 2015 Feb;274(2):352-8. doi: 10.1148/radiol.14140594. Epub 2014 Oct 15. Radiology. 2015. PMID: 25325325

8

Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.

Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW. Park S, et al. Breast. 2012 Feb;21(1):50-7. doi: 10.1016/j.breast.2011.07.008. Epub 2011 Aug 23. Breast. 2012. PMID: 21865043 Free article.

9

Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.

Munzone E, Botteri E, Sandri MT, Esposito A, Adamoli L, Zorzino L, Sciandivasci A, Cassatella MC, Rotmensz N, Aurilio G, Curigliano G, Goldhirsch A, Nolè F. Munzone E, et al. Clin Breast Cancer. 2012 Oct;12(5):340-6. doi: 10.1016/j.clbc.2012.07.001. Clin Breast Cancer. 2012. PMID: 23040002

10

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

Parise CA, Bauer KR, Brown MM, Caggiano V. Parise CA, et al. Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17. Breast J. 2009. PMID: 19764994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed